FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys

FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys

Source: 
Fierce Pharma
snippet: 

Johnson & Johnson’s takeover of COVID-19 vaccine manufacturing at an error-prone Emergent BioSolutions plant in Baltimore didn’t last long.

Two weeks after the U.S. stepped in and handed control of vaccine manufacturing at the plant to J&J, Emergent agreed to temporarily halt producing new drug substance there.